McDermott Will & Emery advised Meiogenix on the round. Meiogenix announced the closing of a USD 13 million (EUR 11 million) Series A financing round led...
Meiogenix’s $13 Million Series A Financing Round
Coave Therapeutics’ €21 Million Funding Round
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...
uniQure’s Acquisition of Corlieve Therapeutics
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...